The Filing Desk

Butterfly Network vs NeuroPace

Butterfly Network BFLY · NeuroPace NPCE · Health Care Equipment

NeuroPace reported revenue of $100 million in fiscal 2025, about the same as Butterfly Network's $98 million in fiscal 2025. Butterfly Network's revenue grew 19.0% in its latest year, and NeuroPace's grew 25.1%. Butterfly Network had an operating margin of -88.5%, against -16.3% at NeuroPace. Free cash flow was −$16 million at Butterfly Network and −$11 million at NeuroPace.

Side by side

Butterfly NetworkNeuroPace
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$98M$100M
Revenue growth19.0%25.1%
Revenue growth a year, last 5 years16.1%19.5%
Gross margin46.9%77.2%
Operating margin−88.5%−16.3%
Net margin−79.0%−21.5%
Free cash flow−$16M−$11M
Free cash flow margin−16.4%−11.3%
Return on capital—−81.8%
Net debt to EBITDA——
Dividends and buybacks$0M$50M
Change in diluted share count16.7%12.3%
Last close$5.85$8.14
P/E at the last close——
Insider trades, last 12 monthsbought $10.7 million, sold $127.7 millionbought $302,102, sold $399,250
Piotroski F-score—5 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Butterfly NetworkNeuroPace
Operating margin
Percent of revenue
Butterfly NetworkNeuroPace
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Butterfly NetworkNeuroPace

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Butterfly Network and NeuroPace pages.